{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T12:33:29Z","timestamp":1763728409037},"reference-count":13,"publisher":"Japanese Society of Internal Medicine","issue":"18","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2023,9,15]]},"DOI":"10.2169\/internalmedicine.1139-22","type":"journal-article","created":{"date-parts":[[2023,2,7]],"date-time":"2023-02-07T22:13:06Z","timestamp":1675807986000},"page":"2737-2741","source":"Crossref","is-referenced-by-count":3,"title":["Ibrutinib Induces a Dramatic Improvement for Idiopathic Refractory Ascites Following Allogeneic Hematopoietic Cell Transplantation"],"prefix":"10.2169","volume":"62","author":[{"given":"Kumiyo","family":"Tazoe","sequence":"first","affiliation":[{"name":"Hematology, Graduate School of Medicine, Osaka Metropolitan University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsutaka","family":"Nishimoto","sequence":"additional","affiliation":[{"name":"Hematology, Graduate School of Medicine, Osaka Metropolitan University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Department of Diagnostic and Interventional Radiology, Graduate School of Medicine, Osaka Metropolitan University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yosuke","family":"Makuuchi","sequence":"additional","affiliation":[{"name":"Hematology, Graduate School of Medicine, Osaka Metropolitan University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masatomo","family":"Kuno","sequence":"additional","affiliation":[{"name":"Hematology, Graduate School of Medicine, Osaka Metropolitan University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Okamura","sequence":"additional","affiliation":[{"name":"Hematology, Graduate School of Medicine, Osaka Metropolitan University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiro","family":"Nakashima","sequence":"additional","affiliation":[{"name":"Hematology, Graduate School of Medicine, Osaka Metropolitan University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sayaka","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Pathology, Graduate School of Medicine, Osaka Metropolitan University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiko","family":"Ohsawa","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Pathology, Graduate School of Medicine, Osaka Metropolitan University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayuki","family":"Hino","sequence":"additional","affiliation":[{"name":"Hematology, Graduate School of Medicine, Osaka Metropolitan University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirohisa","family":"Nakamae","sequence":"additional","affiliation":[{"name":"Hematology, Graduate School of Medicine, Osaka Metropolitan University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Leonard JT, Newell LF, Meyers G, et al. Chronic GvHD-associated serositis and pericarditis. Bone Marrow Transplant 50: 1098-1104, 2015.","DOI":"10.1038\/bmt.2015.105"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Carreras E, D\u00edaz-Bey\u00e1 M, Rosi\u00f1ol L, Mart\u00ednez C, Fern\u00e1ndez-Avil\u00e9s F, Rovira M. The incidence of veno-occlusive disease following allogeneic hematopoietic stem cell transplantation has diminished and the outcome improved over the last decade. Biol Blood Marrow Transplant 17: 1713-1720, 2011.","DOI":"10.1016\/j.bbmt.2011.06.006"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Bonifazi F, Barbato F, Ravaioli F, et al. Diagnosis and treatment of VOD\/SOS after allogeneic hematopoietic stem cell transplantation. Front Immunol 11: 489, 2020.","DOI":"10.3389\/fimmu.2020.00489"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Varma A, Abraham SC, Mehta RS, et al. Idiopathic refractory ascites after allogeneic stem cell transplantation: a previously unrecognized entity. Blood Adv 4: 1296-1306, 2020.","DOI":"10.1182\/bloodadvances.2019000638"},{"key":"5","doi-asserted-by":"publisher","unstructured":"5. Dubovsky JA, Beckwith KA, Natarajan G, et al. Ibrutinib is an irreversible molecular inhibitor of ITK driving a Th1-selective pressure in T lymphocytes. Blood 122: 2539-2549, 2013.","DOI":"10.1182\/blood-2013-06-507947"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Miklos D, Cutler CS, Arora M, et al. Ibrutinib for chronic graft-versus-host disease after failure of prior therapy. Blood 130: 2243-2250, 2017.","DOI":"10.1182\/blood-2017-07-793786"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Jagasia M, Greinix T, Arora M, et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. The 2014 Diagnosis and Staging Working Group report. Biol Blood Marrow Transplant 21: 389-401, 2015.","DOI":"10.1016\/j.bbmt.2015.02.025"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. de Franchis R, Bosch J, Garcia-Tsao G, Reiberger T, Ripoll C; Baveno VII Faculty. Baveno VII - renewing consensus in portal hypertension. J Hepatol 76: 959-974, 2022.","DOI":"10.1007\/978-3-031-08552-9"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Yamamoto A, Kawada N, Jogo A, et al. Utility of minimally invasive measurement of hepatic venous pressure gradient via the peripheral antecubital vein. Gut 70: 1199-1201, 2021.","DOI":"10.1136\/gutjnl-2020-322367"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Shatzel JJ, Olson SR, Tao DL, McCarty OJT, Danilov AV, DeLoughery TG. Ibrutinib-associated bleeding: pathogenesis, management and risk reduction strategies. J Thromb Haemost 15: 835-847, 2017.","DOI":"10.1111\/jth.13651"},{"key":"11","doi-asserted-by":"publisher","unstructured":"11. Tai DI, Tsai SL, Chen YM, et al. Activation of nuclear factor \u03baB in hepatitis C virus infection: implications for pathogenesis and hepatocarcinogenesis. Hepatology 31: 656-664, 2000.","DOI":"10.1002\/hep.510310316"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Shaker ME, Gomaa HAM, Alharbi KS, Al-Sanea MM, El-Mesery ME, Hazem SH. Inhibition of Bruton tyrosine kinase by acalabrutinib dampens lipopolysaccharide\/galactosamine-induced hepatic damage. Biomed Pharmacother 131: 110736, 2020.","DOI":"10.1016\/j.biopha.2020.110736"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Tsuji H, Mukaida N, Harada A, et al. Alleviation of lipopolysaccharide-induced acute liver injury in <i>Propionibacterium acnes<\/i>-primed IFN-\u03b3-deficient mice by a concomitant reduction of TNF-\u03b1, IL-12, and IL-18 production. J Immunol 162: 1049-1055, 1999.","DOI":"10.4049\/jimmunol.162.2.1049"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/62\/18\/62_1139-22\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,16]],"date-time":"2023-09-16T03:23:39Z","timestamp":1694834619000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/62\/18\/62_1139-22\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,15]]},"references-count":13,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.1139-22","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,15]]},"article-number":"1139-22"}}